Inorganic Active Ingredients TRIZ Cases

Retinoic acid and arsenic trioxide target mutant NPM-1 to correct nucleolar localization and reduce bone marrow blasts in NPM-1 mutated AML patients.

Poloxamer entrainers transport vitamin B12 through the skin barrier, overcoming superficial distribution limits of conventional ointments.

Biodegradable polyester backbones replace toxic dendrimers to enable tunable nitric oxide delivery while maintaining high storage capacity.

Chitosan-coated platinum ferrite silica nanocomposites mitigate toxicity and enhance biocompatibility while delivering anticancer drugs with high efficiency.

Merges NO and H2S precursors with antioxidants to repair glycocalyx damage, sustaining bioavailable nitric oxide levels beyond twenty-four hours.

Disulfiram combined with copper modulates redox balance to antagonize NF-kB signaling, overcoming therapeutic resistance in inflammatory breast cancer.

Pairing milciclib with gemcitabine reverses drug resistance in KRAS mutated cancers by leveraging complementary mechanisms to stabilize disease progression.

A pressurized gNO delivery system regulates gas flow and pressure to reduce bioburden in wounds.

Gold-based compounds inhibit mitochondrial respiration to overcome platinum resistance and toxic side effects in cancer treatment.

Microarray analysis detects biomarker levels to predict patient responsiveness, avoiding trial-and-error treatment delays and resistance.

A genomic detection method quantifies large-scale chromosome breaks to predict homologous recombination deficiency.

Phosphatidylcholine vesicles stabilize reactive nitric oxide, enabling controlled release through skin barriers for therapeutic applications.

Dual radical scavengers in a hydrogel neutralize reactive oxygen species, preventing damage to healthy tissue and collagen during wound healing.

Silver compounds administered daily protect red and white blood cells from chemotherapy damage while maintaining cancer treatment efficacy.

Modular cyclopropylamine structures optimize in vitro activity and pharmacokinetic parameters for treating LSD1-related diseases.

Injecting ice slurry via cryolipolysis reduces upper airway fat volume and stimulates tongue collagen production without surgical invasion.

Combining anti-TIGIT antagonists with PD-1 inhibitors and chemotherapy overcomes limited treatment effectiveness to extend overall survival.

HIF prolyl hydroxylase inhibitors stabilize HIF-1α to prevent hyperoxia-induced lung damage and chronic lung disease in premature infants.

Acidic additives inhibit NDMA formation in metformin and valsartan, keeping daily intake below 40 ng to prevent product withdrawals.

Topical potassium channel blockers increase neuronal excitability to treat female sexual dysfunction.

A nitric oxide releasing coating on dental floss eradicates pathogens in the periodontal pocket, addressing limited reach of clinical interventions.

Liquid biochemical scaffold uses harmonic oscillation to transfer energy signatures for cellular modulation.

Short peptide probes replace antibodies to overcome slow binding kinetics and high production costs while maintaining detection reliability.

A scintillating polymer matrix converts penetrating X-ray radiation into localized light to trigger nitric oxide release from a chemical agent.

Copper ions catalyze microbubble rupture at plaque sites to release drugs chemically, preventing mechanical fragmentation and embolism risks.

Acidified copper sulfate liquid eliminates heartworms in dogs without injections, reducing toxicity and veterinary costs.